Please provide your email address to receive an email when new articles are posted on . Corticosteroid use during pregnancy was not linked with developmental milestone delays. Beta-2 adrenergic ...

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

Please provide your email address to receive an email when new articles are posted on . CuraSen Therapeutics has announced positive data from a phase 2a study of its combination adrenergic activator, ...

ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to ...

Recent clinical studies have suggested that phenylacetylglutamine (PAGln), a novel gut microbial metabolite, can mechanistically modulate patients' risk of developing cardiovascular disease (CVD) and ...

A team from Atrogi AB has reported the activity of ATR-127, a novel dual adrenergic agonist targeting β2- and β3-adrenoceptors (ARs), for the potential treatment of steatohepatitis, obesity and ...